Barry Bunin, PhD Founder & CEO Collaborative Drug Discovery Drug Discovery Industry Roundup with Barry Bunin “A.I. Turns Its Artistry to Creating New Human Proteins.” That’s the headline in a recent New York Times article about scientists using OpenAI’s DALL-E software to model proteins that...
Drug Discovery Industry Roundup with Barry Bunin — January 19, 2023 Drug Discovery Industry Roundup with Barry Bunin — January 19, 2023 Barry Bunin, PhD Founder & CEO Collaborative Drug Discovery Drug Discovery Industry Roundup with Barry Bunin “A.I. Turns Its Artistry to Creating New Human Proteins.” That’s the headline in a recent New York Times article about scientists using OpenAI’s DALL-E software to model proteins… by Brian Moore, CDD Webpage: https://ift.tt/I8ueRtX Bengaluru: January 20, 2023 at 06:26AM
Grouping Columns in Visualization The ability to group columns within the Visualization Data Table makes organizing your data a breeze! Once your data is in the Visualization tool, you can: click the Settings button in the corner of the Data Table select the Parameters tab click “Add Group” at t...
CDD Vault Update (January 2023): Comparison Table in Visualization and an Updated Exports API Endpoint Grouping Columns in Visualization The ability to group columns within the Visualization Data Table makes organizing your data a breeze! Once your data is in the Visualization tool, you can: click the Settings button in the corner of the Data Table select the Parameters tab click “Add Group” at the bottom give each Group a… by Abe Wang, CDD Webpage: https://ift.tt/RuXoiGV Bengaluru: January 08, 2023 at 01:24AM
Barry Bunin, PhDFounder & CEOCollaborative Drug Discovery AI + Machine Learning = Inflection Point for Biopharma. That’s the 2023 forecast from FIERCE Pharma, which points to a flood of AI and machine learning products. The article describes new offerings from a number of companies seeking to “r...
Drug Discovery Industry Roundup with Barry Bunin — January 4, 2023 Drug Discovery Industry Roundup with Barry Bunin — January 4, 2023 Barry Bunin, PhD Founder & CEO Collaborative Drug Discovery AI + Machine Learning = Inflection Point for Biopharma. That’s the 2023 forecast from FIERCE Pharma, which points to a flood of AI and machine learning products. The article describes new offerings from a number… by Brian Moore, CDD Webpage: https://ift.tt/xaq5Biu Bengaluru: January 05, 2023 at 01:23AM
Protocol Searching When defining a search in the main Explore Data > Search tab, users can find the precise Protocol to query by typing any portion of the Protocol Name. This new interface will display results as you type. Hovering on Atoms in the Structure Editor In the Ketcher Structure Editor, at...
CDD Vault Update (December 2022 [#2]): New Protocol Search & Structure Editor Features Protocol Searching When defining a search in the main Explore Data > Search tab, users can find the precise Protocol to query by typing any portion of the Protocol Name. This new interface will display results as you type. Hovering on Atoms in the Structure Editor In the Ketcher Structure Editor, atoms can be changed… by Abe Wang, CDD Webpage: https://ift.tt/7v6It24 Bengaluru: December 27, 2022 at 11:23PM
leadership CDD will be at the 41st Annual J.P. Morgan Healthcare Conference, as well as the RESI Conference, both in San Francisco in January 2023. Our CEO, Dr. Barry Bunin, will be introducing the just launched PharmaKB.com – The Pharmaceutical Knowledgebase™ – offering comprehensive and upda...
CDD Attending JP Morgan Healthcare Conference, San Francisco, January 9-12, 2023 CDD Attending JP Morgan Healthcare Conference, San Francisco, January 9-12, 2023 January 9-12, 2023 • San Francisco CDD will be at the 41st Annual J.P. Morgan Healthcare Conference, as well as the RESI Conference, both in San Francisco in January 2023. Our CEO, Dr. Barry Bunin, will be introducing the just launched PharmaKB.com - The Pharmaceutical… by Brian Moore, CDD Webpage: https://ift.tt/uNljEW3 Bengaluru: December 24, 2022 at 12:24AM
The $279,970 supplemental grant from National Library of Medicine will allow CDD to develop Automated Molecular Identity Disambiguator (AutoMID) Burlingame, California – December 19, 2022 – Collaborative Drug Discovery, in collaboration with University of Miami, has received a $279.970 grant fro...
Collaborative Drug Discovery Announces New NIH Grant to Develop Automated Molecular Identity Disambiguator Collaborative Drug Discovery Announces New NIH Grant to Develop Automated Molecular Identity Disambiguator The $279,970 supplemental grant from National Library of Medicine will allow CDD to develop Automated Molecular Identity Disambiguator (AutoMID) Burlingame, California — December 19, 2022 — Collaborative Drug Discovery, in collaboration with University of Miami, has received a $279.970 grant from National… by Brian Moore, CDD Webpage: https://ift.tt/PaWuy76 Bengaluru: December 19, 2022 at 07:27PM
The $440,000 grant from National Center for Advancing Translational Sciences will allow CDD to develop virtual approaches to new chemistries Burlingame, California – November 21, 2022 – Collaborative Drug Discovery has received a $440,000 grant from National Center for Advancing Translational Sc...
Collaborative Drug Discovery Announces New NIH Grant to Develop Virtual Approaches to New Chemistries Collaborative Drug Discovery Announces New NIH Grant to Develop Virtual Approaches to New Chemistries The $440,000 grant from National Center for Advancing Translational Sciences will allow CDD to develop virtual approaches to new chemistries Burlingame, California — November 21, 2022 — Collaborative Drug Discovery has received a $440,000 grant from National Center for Advancing Translational… by Brian Moore, CDD Webpage: https://ift.tt/RsVNY1v Bengaluru: December 12, 2022 at 07:23PM |
Zastra's JournalArchives
April 2023
Categories |